Volume 14, Issue 2 (May 2026)
Res Mol Med (RMM) 2026, 14(2): 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Taghizadeh S, Gorgani M, Parsamanesh G, Jazayeri M H, Nickho H. Conventional and Targeted Therapeutic Approaches in Multiple Sclerosis: A Narrative Review of Disease-Modifying Therapies, Nanoparticles, and Exosomes. Res Mol Med (RMM) 2026; 14 (2)
URL: http://rmm.mazums.ac.ir/article-1-649-en.html
URL: http://rmm.mazums.ac.ir/article-1-649-en.html
1- Department of Medical Sciences, Shahrood Center, Islamic Azad University, Shahrood, Iran. & Nanoparticle Research Center in Medicine, Shahrood Center, Islamic Azad University, Shahrood, Iran , shirintaghizadeh@ymail.com
2- Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
3- Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
4- Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran & Immunology Research Center, Institute of Immunology and Infectious Disease, Iran University of Medical Sciences, Tehran, Iran
5- Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran & Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran
2- Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
3- Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
4- Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran & Immunology Research Center, Institute of Immunology and Infectious Disease, Iran University of Medical Sciences, Tehran, Iran
5- Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran & Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran
Abstract: (202 Views)
Multiple sclerosis (MS) is a chronic immune-mediated neurodegenerative disease of the central nervous system (CNS) characterized by inflammation, demyelination, and progressive neurological disability. Conventional disease-modifying therapies, including interferon-beta, glatiramer acetate, sphingosine-1-phosphate modulators, anti-CD20 antibodies, and immune reconstitution strategies, can reduce relapse activity and disease burden; however, their efficacy is limited by adverse effects, incomplete control of compartmentalized central nervous system (CNS) inflammation, and insufficient target specificity. In parallel, nanoparticles and exosomes have emerged as promising targeted platforms for drug delivery and immunomodulation because they may enhance blood-brain barrier (BBB) penetration and improve cell-specific delivery. This narrative review summarizes conventional and targeted therapeutic approaches in multiple sclerosis (MS), with emphasis on the translational promise and limitations of nanoparticle- and exosome-based strategies. Preclinical evidence from experimental autoimmune encephalomyelitis models and human clinical data are distinguished where appropriate. The review also highlights the major barriers that must be addressed before these approaches can be translated into routine clinical practice.
Keywords: Multiple Sclerosis, Treatment of multiple sclerosis, Conventional Treatments, Nanoparticles, Exosomes, Targeted Therapy, Narrative Review
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
